NSAID increases liver damage in mice carrying mutant human gene
The large globules in the liver cells on the left are characteristic of alpha-1-antitrypsin deficiency. The image on the right shows normal liver cells.Research performed at Washington University School of Medicine in St. Louis sheds light on the mechanisms that contribute to liver disease in alpha-1-AT deficiency patients. People with alpha-1-deficiency have a genetic mutation that can lead to emphysema at an early age and to liver damage. Using an experimental mouse model of the disorder, the researchers investigated the effects of a non-steroidal anti-inflammatory drug (NSAID) on liver injury.
Seven-point system gauges seriousness of heart failure in elderly
A simple points system may soon help guide treatment of elderly heart failure patients. Researchers at Washington University School of Medicine in St. Louis found that by counting how many of seven easy-to-obtain health factors a patient has, physicians can estimate the patient’s risk of dying.
Researchers study reimbursing living organ donors for out-of-pocket expenses
More than 80,000 people in the United States are on waiting lists for organ transplants. Some will have to wait for the death of a matching donor, but more and more people are receiving organs from living donors. In an effort to close the gap between organ supply and demand, researchers at Washington University School of Medicine, the University of Michigan and the American Society of Transplant Surgeons are studying ways to reimburse living donors for some of their out-of-pocket expenses when they choose to donate an organ.
Antibody reduces acute rejection in high-risk kidney transplant patients
Nearly 70 percent of kidney transplant patients get short-term drug therapy initially administered during surgery to help prevent rejection. In the first head-to-head comparison of the two drugs most commonly given to ward off acute kidney rejection, an international study led by researchers at Washington University School of Medicine in St. Louis shows that one – anti-thymocyte globulin – is superior.
Common cause of heart disease, diabetes may be treatable with malaria drug
Studies of a rare genetic condition that increases cancer risk have unveiled a potential treatment for metabolic syndrome, a common disorder that afflicts as many as one in every four American adults and puts them at sharply increased risk of type 2 diabetes and clogged arteries.
Naturally occurring enzyme can break down Alzheimer’s plaques
A finding by School of Medicine researchers could allow them to seek new therapies and understand what goes wrong in the brains of Alzheimer’s patients.
Students get hands-on experience in Forest Park Southeast
Photo by Beth MillerTheodore Armstrong, a pre-doctoral fellow, and Jourdan Stuart, a first-year medical student, discuss a patient they examined with Will R. Ross, M.D., faculty supervisor, assistant professor of medicine and associate dean for diversity, at the Saturday Neighborhood Health Clinic in the Forest Park Southeast neighborhood.School of Medicine students are learning about social medicine on Saturday mornings in Forest Park Southeast.
Kelly named director of cardiovascular division
Daniel Kelly, M.D., has been named director of the Division of Cardiovascular Diseases in the Department of Medicine.
Shapiro to give Dean’s Update
Dean Shapiro plans to give updates on the School of Medicine’s key initiatives, including the tobacco-free initiative, addressing pandemic flu, and the New Interstate 64 project.
Amendment 2 passage urged by Missouri’s top medical educators
Deans and top administrators from Missouri’s seven medical higher education institutions have joined to urge the passage of the Missouri Stem Cell Research and Cures Initiative.
View More Stories